Stay updated on VS-6766 and Everolimus Clinical Trial

Sign up to get notified when there's something new on the VS-6766 and Everolimus Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the VS-6766 and Everolimus Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The page has removed a citation regarding a study on the oral RAF-MEK inhibitor CH5126766/VS-6766, which was previously included.
    Difference
    0.4%
    Check dated 2025-05-08T14:04:31.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.3%
    Check dated 2025-05-01T06:24:24.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The web page has been updated to reflect new collaborators and a revision number, while significant details about the trial's methodology and patient criteria have been removed.
    Difference
    50%
    Check dated 2025-04-16T20:42:33.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.3%
    Check dated 2025-04-09T16:03:59.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.3%
    Check dated 2025-04-02T00:26:26.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-03-18T14:43:17.000Z thumbnail image

Stay in the know with updates to VS-6766 and Everolimus Clinical Trial

Enter your email address, and we'll notify you when there's something new on the VS-6766 and Everolimus Clinical Trial page.